Angela Zubel
InvestorChief Development Officer, Research & Development at Debiopharm Innovation Fund
Japan
Find your path to Angela
197 people in our graph share verified history with Angela — schools, employers, funds. One of them is your warm intro.
Giovanni MariggiunlockedAngela: together at Healthcare Business of Merck (2005–2006)
Angela: together at Sandoz
Angela: together at Healthcare Business of Merck
×5Angela: together at Heidelberg University
About
Chief Development Officer for R&D who joined Debiopharm International in 2019. She holds an MD from Jagiellonian University Krakow and a PhD from the German Cancer Research Center, with prior roles at Merck Serono, Novartis and Sandoz.
Experience
- Debiopharm International SAChief Development Officercurrent2019 — presentLausanne, Vaud, Switzerland
- SandozGlobal Head Clinical Development Biopharmaceuticals a.i.2017 — 2019Greater Munich Metropolitan Area
- SandozClinical Development Unit Head, Oncology2016 — 2017Greater Munich Metropolitan Area
- Novartis Institutes for BioMedical Research (NIBR)Clinical Program Leader, Oncology2011 — 2016Basel, Basel, Switzerland
- Healthcare Business of MerckMedical Leader, Oncology2004 — 2010Darmstadt, Hesse, Germany
Colleagues at Debiopharm Innovation Fund
Bertrand Ducrey
Chief Executive Officer, Debiopharm International & Senior Vice-Chairman, Debiopharm at Debiopharm Innovation Fund
Cedric Odje
Investment Associate at Debiopharm Innovation Fund
Chris Thomas
Director, Investments at Wollemi Capital
David Shin
Investor at Dash Fund
Dawid Książczak
Chief Legal Officer at McWin Capital Partners
Frédéric Lévy
Chief Scientific Officer, Search & Evaluation and Scientific Innovation at Debiopharm Innovation Fund
Kavita Patel
Principal at Muus Climate Partners
Kerstin Planitzer-Zipf
Chief Compliance Officer at Cipio Partners
Frequently asked questions
- Who is Angela Zubel?
- Chief Development Officer for R&D who joined Debiopharm International in 2019. She holds an MD from Jagiellonian University Krakow and a PhD from the German Cancer Research Center, with prior roles at Merck Serono, Novartis and Sandoz.
- Where does Angela Zubel work?
- Angela Zubel is Chief Development Officer, Research & Development at Debiopharm Innovation Fund.
- Where did Angela Zubel go to school?
- Angela Zubel studied at Heidelberg University (Doctor of Medicine - MD); Jagiellonian University.
Same school
Also attended Heidelberg University100
Mojca SkoberneEntrepreneur in Residence at GV (Google Ventures)Keita Yazakiシニア・アソシエイト (Senior Associate) at CyberAgent CapitalGrace SchattnerChief of Staff at TitletownTechLena ThiedeCo-Founder & General Partner at Planet A VenturesFabian HeilemannFounder & CEO at AENUJan MarchewskiPrincipal at Hitachi Ventures
+ 94 more
Also attended Jagiellonian University34
Ola JewusiakVP of Marketing at Jump CapitalMarguerite BensonSenior Advisor at Audere CapitalMagda PoslusznyPrincipal at Partech VenturesJoanna SorokaInvestment Partner at Hitachi VenturesAlexander KölpinFounder and Managing Director at Seed+SpeedDominik DlugoszPartner at Innovation Nest
+ 28 more
Shared employers
Also worked at Sandoz29
Nikita SharmaPrincipal at Versant VenturesCarol LynchAdvisor at Delin VenturesShreeram AradhyeInvestor at Novartis Venture FundMax PalkoPrincipal at Rockaway VenturesIain RossNon-Executive Director at TernLaura MockDirector at Cultivator Powered by Conexus
+ 23 more
Also worked at Novartis Institutes for BioMedical Research (NIBR)332
Rebecca JamesInvestor at Index VenturesScott BillerInvestor at GV (Google Ventures)Freya Svedberg-KeatingInvestor at MedicxiAndrea AmadorCompliance Manager at Inveready Technology Investment GroupAbbie CelnikerInvestor at Third Rock VenturesJesper GromadaInvestor at Third Rock Ventures
+ 326 more
Also worked at Healthcare Business of Merck25
Giovanni MariggiInvestor at MedicxiRoel BulthuisInvestor at SynconaMathias FalcenbergVenture Partner at V-Bio VenturesParis PanayiotopoulosSenior Managing Director at Blackstone Life SciencesFrederic WohlwendManaging Partner at Forestay CapitalAlicia Irurzun-LafittePartner at UCB Ventures
+ 19 more